Literature DB >> 27621504

Sodium Thiosulfate: Calciphylaxis.

Joyce A Generali1, Dennis J Cada2.   

Abstract

This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature enables the health care professional or clinician to quickly identify published studies on off-label uses and determine if a specific use is rational in a patient care scenario. References direct the reader to the full literature for more comprehensive information before patient care decisions are made. Direct questions or comments regarding Off-Label Drug Uses to jgeneral@ku.edu.

Entities:  

Year:  2015        PMID: 27621504      PMCID: PMC4750847          DOI: 10.1310/hpj5011-975

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  9 in total

1.  Successful treatment of calciphylaxis with intravenous sodium thiosulfate.

Authors:  Jeffrey S Cicone; John B Petronis; Carmen D Embert; David A Spector
Journal:  Am J Kidney Dis       Date:  2004-06       Impact factor: 8.860

Review 2.  Treatment of cutaneous calciphylaxis with sodium thiosulfate: two case reports and a review of the literature.

Authors:  Matteo Auriemma; Angelo Carbone; Lorenzo Di Liberato; Antonietta Cupaiolo; Chiara Caponio; Clara De Simone; Antonio Tulli; Mario Bonomini; Paolo Amerio
Journal:  Am J Clin Dermatol       Date:  2011-10-01       Impact factor: 7.403

3.  Calciphylaxis responding to sodium thiosulfate therapy.

Authors:  Brian L Baker; Carrie A Fitzgibbons; Lucinda S Buescher
Journal:  Arch Dermatol       Date:  2007-02

4.  Sodium thiosulfate as first-line treatment for calciphylaxis.

Authors:  Felix Ackermann; Annabelle Levy; Eric Daugas; Noel Schartz; Anne Riaux; Christian Derancourt; Pablo Urena; Celeste Lebbé
Journal:  Arch Dermatol       Date:  2007-10

5.  Complete resolution of recurrent calciphylaxis with long-term intravenous sodium thiosulfate.

Authors:  Kavitha Subramaniam; Hilary Wallace; Rajalingam Sinniah; Barry Saker
Journal:  Australas J Dermatol       Date:  2008-02       Impact factor: 2.875

6.  Long-term intravenous sodium thiosulfate in the treatment of a patient with calciphylaxis.

Authors:  Michael Brucculeri; Jhoong Cheigh; Gregory Bauer; David Serur
Journal:  Semin Dial       Date:  2005 Sep-Oct       Impact factor: 3.455

7.  Sodium thiosulfate therapy for calcific uremic arteriolopathy.

Authors:  Sagar U Nigwekar; Steven M Brunelli; Debra Meade; Weiling Wang; Jeffrey Hymes; Eduardo Lacson
Journal:  Clin J Am Soc Nephrol       Date:  2013-03-21       Impact factor: 8.237

8.  Calciphylaxis in a patient with normal renal function: response to treatment with sodium thiosulfate.

Authors:  B C Hackett; M A McAleer; G Sheehan; F C Powell; B F O'Donnell
Journal:  Clin Exp Dermatol       Date:  2008-07-04       Impact factor: 3.470

9.  Severe anion gap acidosis associated with intravenous sodium thiosulfate administration.

Authors:  Michael Mao; Sarah Lee; Kianoush Kashani; Robert Albright; Qi Qian
Journal:  J Med Toxicol       Date:  2013-09
  9 in total
  3 in total

Review 1.  An update on vascular calcification and potential therapeutics.

Authors:  Anubha Singh; Simran Tandon; Chanderdeep Tandon
Journal:  Mol Biol Rep       Date:  2021-01-04       Impact factor: 2.316

Review 2.  N-Acetylcysteine and Other Sulfur-Donors as a Preventative and Adjunct Therapy for COVID-19.

Authors:  Heidi N du Preez; Colleen Aldous; Hendrik G Kruger; Lin Johnson
Journal:  Adv Pharmacol Pharm Sci       Date:  2022-08-10

3.  Isolated Penile Calciphylaxis Diagnosed by Ultrasound Imaging in a New Dialysis Patient: A Case Report.

Authors:  Wryan Helmeczi; Tyler Pitre; Emma Hudson; Suhas Mondhe; Kevin Burns
Journal:  Can J Kidney Health Dis       Date:  2021-07-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.